IL187138A0 - Compositions and methods for treating conditions related to ephrin signaling with cupredoxins - Google Patents
Compositions and methods for treating conditions related to ephrin signaling with cupredoxinsInfo
- Publication number
- IL187138A0 IL187138A0 IL187138A IL18713807A IL187138A0 IL 187138 A0 IL187138 A0 IL 187138A0 IL 187138 A IL187138 A IL 187138A IL 18713807 A IL18713807 A IL 18713807A IL 187138 A0 IL187138 A0 IL 187138A0
- Authority
- IL
- Israel
- Prior art keywords
- cupredoxins
- compositions
- methods
- conditions related
- treating conditions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68281205P | 2005-05-20 | 2005-05-20 | |
US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
US76474906P | 2006-02-03 | 2006-02-03 | |
PCT/US2006/019684 WO2007018671A2 (en) | 2005-05-20 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL187138A0 true IL187138A0 (en) | 2008-02-09 |
Family
ID=37727776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL187138A IL187138A0 (en) | 2005-05-20 | 2007-11-04 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1888106A4 (en) |
JP (1) | JP2008539795A (en) |
KR (1) | KR20080040631A (en) |
AU (1) | AU2006277009A1 (en) |
BR (1) | BRPI0612424A2 (en) |
CA (1) | CA2608512A1 (en) |
IL (1) | IL187138A0 (en) |
MX (1) | MX2007014598A (en) |
NO (1) | NO20076391L (en) |
WO (1) | WO2007018671A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
AU2005327535A1 (en) | 2004-10-07 | 2006-08-24 | Ananda Chakrabarty | Cupredoxin derived transport agents and methods of use thereof |
JP2009502797A (en) * | 2005-07-19 | 2009-01-29 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | Compositions and methods for controlling angiogenesis with cupredoxins |
EP1904642A4 (en) | 2005-07-19 | 2008-11-26 | Univ Illinois | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
BRPI0714987A2 (en) * | 2006-09-14 | 2013-07-30 | Trutees Of The University Of Illinoi Board Of | cupredoxin cancer prevention compositions and methods |
EP2117573A4 (en) * | 2007-01-11 | 2011-02-16 | Univ Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
PL2199390T3 (en) | 2007-08-30 | 2017-06-30 | Daiichi Sankyo Company, Limited | Anti-epha2 antibody |
KR101102829B1 (en) * | 2008-09-12 | 2012-01-05 | 재단법인 제주테크노파크 | Extract of Ulva pertusa and Its Use as Anti-inflammatory Medicine |
CN110090295B (en) * | 2018-01-29 | 2022-12-23 | 武汉康理通科技有限公司 | Application of Ephrin-B1 in preparation of medicine for treating inflammatory bowel disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1411963A4 (en) * | 2001-02-15 | 2005-01-19 | Univ Illinois | Cytotoxic factors for modulating cell death |
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
-
2006
- 2006-05-19 EP EP06813192A patent/EP1888106A4/en not_active Withdrawn
- 2006-05-19 JP JP2008512587A patent/JP2008539795A/en active Pending
- 2006-05-19 CA CA002608512A patent/CA2608512A1/en not_active Abandoned
- 2006-05-19 KR KR1020077028984A patent/KR20080040631A/en not_active Application Discontinuation
- 2006-05-19 BR BRPI0612424-0A patent/BRPI0612424A2/en not_active IP Right Cessation
- 2006-05-19 MX MX2007014598A patent/MX2007014598A/en active IP Right Grant
- 2006-05-19 WO PCT/US2006/019684 patent/WO2007018671A2/en active Application Filing
- 2006-05-19 AU AU2006277009A patent/AU2006277009A1/en not_active Abandoned
-
2007
- 2007-11-04 IL IL187138A patent/IL187138A0/en unknown
- 2007-12-11 NO NO20076391A patent/NO20076391L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0612424A2 (en) | 2009-01-27 |
AU2006277009A1 (en) | 2007-02-15 |
KR20080040631A (en) | 2008-05-08 |
EP1888106A2 (en) | 2008-02-20 |
WO2007018671A2 (en) | 2007-02-15 |
MX2007014598A (en) | 2008-02-07 |
WO2007018671A3 (en) | 2007-11-22 |
EP1888106A4 (en) | 2009-01-14 |
NO20076391L (en) | 2008-02-15 |
JP2008539795A (en) | 2008-11-20 |
CA2608512A1 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL187138A0 (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins | |
AP2885A (en) | Methods and compositions for improving plant health | |
EP1899480A4 (en) | Compositions and methods for treating inflammatory conditions | |
ZA200800187B (en) | Methods for increasing the resistance of plants to hypoxic conditions | |
GB2469243B (en) | Improvements in or relating to ablutionary installations | |
IL184698A0 (en) | Composition and method for improving plant health | |
IL229039A0 (en) | Solid compositions and methods for treating middle-of-the night insomnia | |
EP1895838A4 (en) | Compositions and methods | |
LT2137210T (en) | Novel method and compositions | |
EP2101731A4 (en) | Endoxifen methods and compositions | |
IL191237A0 (en) | Compositions and methods for treating thrombocytopenia | |
IL197602A0 (en) | Compositions and methods to prevent cancer with cupredoxins | |
EP2088865A4 (en) | Guggulphospholipid methods and compositions | |
GB0617171D0 (en) | Novel compositions and methods | |
GB0524927D0 (en) | Compositions and method | |
ZA200710205B (en) | Solid compositions and methods for treating middle-of-the night insomnia | |
EP2278984A4 (en) | Compositions and methods for enhancing fertility | |
GB0501348D0 (en) | Compositions and methods | |
GB0511235D0 (en) | Compositions and method | |
ZA200709939B (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins | |
EP2059122A4 (en) | Methods and compositions related to apobec-1 expression | |
GB0500224D0 (en) | Improvements in or relating to ablutionary installations | |
GB0714599D0 (en) | Composition and methods relating to photopolymer | |
EP2117573A4 (en) | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof | |
EP2032146A4 (en) | Methods and compositions related to tr4 |